TCT-438 Outcomes After Bailout Stenting with Absorb BVS or XIENCE: Meta-analysis of Randomized Trials

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2016)

Cited 0|Views22
No score
Abstract
The Absorb bioresorbable scaffold (BVS) provides comparable 12-month clinical outcomes to Xience everolimus-eluting stents in appropriately sized vessels. Differences in device structure (strut thickness and width) and resorption might impact outcomes in the setting of bailout (unplanned) device
More
Translated text
Key words
stenting,outcomes,bailout,absorb bvs,trials,meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined